1. Home
  2. YDKG vs BRTX Comparison

YDKG vs BRTX Comparison

Compare YDKG & BRTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

YDKG

Yueda Digital Holding Class A Ordinary Share

HOLD

Current Price

$1.09

Market Cap

5.3M

ML Signal

HOLD

Logo BioRestorative Therapies Inc. (NV)

BRTX

BioRestorative Therapies Inc. (NV)

HOLD

Current Price

$0.22

Market Cap

5.5M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
YDKG
BRTX
Founded
2005
1997
Country
China
United States
Employees
N/A
14
Industry
Advertising
Managed Health Care
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
5.3M
5.5M
IPO Year
2007
2015

Fundamental Metrics

Financial Performance
Metric
YDKG
BRTX
Price
$1.09
$0.22
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
20.1K
339.7K
Earning Date
05-12-2026
05-13-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$81,000.00
Revenue This Year
N/A
$298.39
Revenue Next Year
N/A
$64.62
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.02
$0.16
52 Week High
$3.90
$1.89

Technical Indicators

Market Signals
Indicator
YDKG
BRTX
Relative Strength Index (RSI) 58.16 36.57
Support Level $0.81 $0.19
Resistance Level $1.15 $0.24
Average True Range (ATR) 0.06 0.02
MACD -0.00 0.01
Stochastic Oscillator 57.14 46.19

Price Performance

Historical Comparison
YDKG
BRTX

About YDKG Yueda Digital Holding Class A Ordinary Share

Yueda Digital Holding is a Web3 and digital company with a focus on the long-term accumulation of mainstream cryptocurrencies. The business activities of the company include active treasury management of mainstream digital assets, exploration of compliant, risk-managed yield opportunities, such as staking, on-chain liquidity provision, and other conservative market activities, selective investments and partnerships in Web3 infrastructure and applications, and advisory services for enterprises entering the digital-asset economy.

About BRTX BioRestorative Therapies Inc. (NV)

BioRestorative Therapies Inc is engaged in developing therapeutic products using cell and tissue protocols, involving adult stem cells. The company is pursuing its Disc/Spine Program with initial investigational therapeutic product being called BRTX-100 in the treatment of chronic cervical discogenic pain. The technology is an stem cell injection procedure that may offer relief from lower back pain, buttock and leg pain, and numbness and tingling in the leg and foot. It is also developing ThermoStem Program, a pre-clinical program which involves the use of brown adipose (fat) in connection with the cell-based treatment of type 2 diabetes and obesity as well as hypertension, other metabolic disorders and cardiac deficiencies.

Share on Social Networks: